ArticleJCO precision oncology2026
Novel Genomic Biomarkers Improve Post-Hematopoietic Cell Transplantation Relapse Risk Stratification for Patients With Myelodysplastic Syndromes.
Tao Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.